Figure 2:The mean choroidal thickness is measured by spectral-domain optical coherence tomography at the fovea, 2 and 1mm temporally, and 2 and 1mm nasally before (closed) and 1 (open) and 3 months (gray) after intravitreal bevacizumab (IVB) injection for myopic choroidal neovascularization. The mean choroidal thickness has decreasedsignificantly at the fovea, and 1 and 2 mm temporally 1 month after IVB. However, the significance is lost 3 months after IVB; this decreaseis still of borderline significance 2mm temporally. Bar=standard deviation. *P<0.05, †P=0.06.